Abstract
Digital pathology (DP) is transitioning from an adjunct technology to an enterprise diagnostic platform in the United States. Despite accelerating clinical adoption, many laboratories face persistent barriers, including high capital and operating costs, workflow disruption, interoperability challenges, and a complex regulatory and reimbursement environment. This narrative review proposes a practical lifecycle framework for implementing and sustaining DP programs, with an emphasis on defining and operationalizing institutional artificial intelligence (AI) readiness for safe and sustainable adoption.